A Mismatch Repair-Deficient Hepatoid Adenocarcinoma of the Lung Responding to Anti-PD-L1 Durvalumab Therapy Despite no PD-L1 Expression. - Basse V; Schick U; Guéguen P; Le Maréchal C; Quintin-Roué I; Descourt R; Simon H; Uguen A; Quéré G (Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2018)